BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Aeon Astron Europe B.V. is recruiting distributors for its plastic and general surgery product

Leiden (the Netherlands) April 30, 2008.  Aeon Astron Europe B.V. (AAE) a corporate dedicates to research and supply of biomaterials in the field of tissue repair and augmentation is now recruiting distributors for its collagen matrix. It is a biocompatible and safe biomedical device and is indicated for dental, plastic and general surgery. This product is already CE approved and FDA 510K submitted.

The approved collagen matrix attempts to restore connective and epithelium tissues where damage, weakness or loose exists. The extended use of Aongen™ includes body contouring procedure, such as abdominoplasties, aesthetic facial surgeries or dental surgery applications. By applying AAE’s collagen matrix (Aongen™) , it can modulate the wound healing and create a physiological and regenerative growth on implant site. Therefore, Aongen™ act as a good ECM (Extra Cellular Matrix) scaffold facilitating the wound healing and guiding a physiological wound modulation. Aongen™ collagen matrix is applied to dental, plastic and general applications.
In ophthalmology, the use of this ologen™ collagen matrix has been expanding gradually from Europe to Middle East. Distributors in Central and South America are now under registration for actively marketing this product in those areas.

Research and Development:

AAE is dedicated to the sales and marketing for the products that Body Organ Biomedical Corporation (BOBC) and Aeon Astron Corporation (AAC) have developed. Currently BOBC has some projects undergoing that includes bio cornea, Hylauronic Acid (HA) and Col-Hap matrix for tissue reapir and augmentation in plastic surgery and orthopedic; and drug bonding release technology. These patents have been filed and can be developed into more than 6 to 8 different applications in ophthalmology, plastic and aesthetic, general and orthopedic applications.

AAE, 100% owned by AAC, will be the marketing tool for all these novel innovative and breakthrough products in the medical world. For more information, please visit www.aeonastron.com or contact us.

Contact Info
PRAAE@aeonastron.net 
Tel: +31 71 3322280
Fax: +31 71 3322281
Add: Niels Bohrweg 11-13, 2333 CA Leiden, The Netherlands
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.